Objective
To compare the gestational age of neonates in utero exposed to benzodiazepines (BDZs) with none exposed controls. Secondary objectives were; birth weight, presence of congenital malformations, APGAR score, and the need for > 3 months (prolonged) maternal psychiatric care.